Page 18 - Pharmaceutical
Amend Drugs and Cosmetics Act to promote e-pharmacy in India
While e-pharmacy offers convenience to people, there are concerns with respect to legitimacy of e-pharmacies, patients' safety and privacy, adverse effect on retailers business, etc
 "Amend Drugs and Cosmetics Act to promote e-pharmacy in India")
Sun Pharma signs licensing pact with Spain's Almirall for tildrakizumab in Europe
As per the agreement, which will fetch Sun Pharma $ 50 mn as an initial upfront payment, Almirall will lead the marketing effort of tildrakizumab for treatment of psoriasis in Europe
 "Sun Pharma signs licensing pact with Spain's Almirall for tildrakizumab in Europe")
RPG Life Sciences buys Sun Pharma's 7 brands for Rs 41 crore
Divested products include brands used for treatment of respiratory-track infections, urological disorders, cardiovascular diseases, etc
 "RPG Life Sciences buys Sun Pharma's 7 brands for Rs 41 crore")
Vivimed arm Klar Sehen divests certain products to Ordain Healthcare for Rs 73 cr
The move is part of Vivimed's strategy to exit from the branded formulations in ophthalmology and to focus on CMO and US generic business
 "Vivimed arm Klar Sehen divests certain products to Ordain Healthcare for Rs 73 cr")
European drug regulator suspends medicines tested at Semler Research
European Medicines Agency has cited flaws in bioequivalence studies, which are required for the approval of generics, conducted at the Bangalore-based CRO as the reasons for suspension
 "European drug regulator suspends medicines tested at Semler Research")
US FDA grants approval for Glenmark's skin ointment
The approved product, triamcinolone acetonide ointment (0.5 percent), achieved annual sales of about $ 4.4 million in the US, according to IMS Health
European drug regulator accepts Mylan-Biocon application for biosimilar Pegfilgrastim
The proposed biosimilar Pegfilgrastim, used to treat cancer, is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace
 "European drug regulator accepts Mylan-Biocon application for biosimilar Pegfilgrastim")
Ajanta Pharma receives US FDA approval for omeprazole capsules
The company has launched omeprazole and sodium bicarbonate capsule, a generic version of Santarus Inc's Zegerid, in two strengths - 20 mg/1100 mg and 40 mg/1100 mg
 "Ajanta Pharma receives US FDA approval for omeprazole capsules")
SPARC licenses epilepsy drug Elepsia XR to Sun Pharma
The company will receive an up-front payment of $10 million from Sun Pharma, which will market the product (levetiracetam extended release tablets) in the US
 "SPARC licenses epilepsy drug Elepsia XR to Sun Pharma")
Biocon introduces insulin glargine in Japan for diabetes patient
The company, through its partner Fujifilm Pharma, aims to capture a significant share of the Japanese glargine market, estimated by IMS Health at $ 144 million
Amgen and Daiichi Sankyo to jointly commercialise biosimilars in Japan
The deal includes several products in late-stage development, including biosimilars of adalimumab, bevacizumab and trastuzumab
 "Amgen and Daiichi Sankyo to jointly commercialise biosimilars in Japan")
Vascon Engineers opens clean room partitioning systems plant in Thane
While clean room partitioning systems are mainly used in pharma and healthcare industry, demand is also expected to come from defence, auto component, semi-conductor and solar sectors
 "Vascon Engineers opens clean room partitioning systems plant in Thane")
Indian companies gearing up to solve the biosimilars puzzle
US President is pushing for setting the exclusivity period for biologic drugs at 7 years instead of 12. If this happens, Indian companies should be ready for a windfall of opportunities
 "Indian companies gearing up to solve the biosimilars puzzle")
AMRI completes acquisition of Italian API maker Euticals
The acquisition positions AMRI as one of the largest independent developers and suppliers of active pharmaceutical ingredients (APIs) to the pharmaceutical industry in Europe
 "AMRI completes acquisition of Italian API maker Euticals")
Apax Partners acquires subsidiaries of Spanish pharma firm Invent Farma
This follows Apax Partners' recent acquisition of Neuraxpharm Arzneimittel GmbH, a leading German pharmaceutical company
Cipla aims to make biosimilars affordable with new South African plant
The new plant, to be built with an investment of about Rs 600 crore, will be run independently of existing pharma manufacturing division, Cipla Medpro Manufacturing
 "Cipla aims to make biosimilars affordable with new South African plant")
India should reject efforts weakening access to generic drugs
MSF urged Modi to defend India's lifeline to South Africa and developing countries through affordable versions of new medicines
 "India should reject efforts weakening access to generic drugs")
India beats China in pharma exports: Commerce Ministry
According to the Ministry, India's pharma exports grew from $ 11.66 billion to $ 12.54 billion in 2015, while China increased its exports from $ 6.59 billion to $ 6.94 billion
 "India beats China in pharma exports: Commerce Ministry")
Novo Nordisk invests $ 59 mn to expand insulin plant in Denmark
Kalundborg facility produces 50 percent of the world's insulin as well as a range of biopharmaceutical products
 "Novo Nordisk invests $ 59 mn to expand insulin plant in Denmark")
FDC receives US FDA's positive inspection report for Baddi plant
However, the company has received two minor observations from the US drug regulator for its Waluj (Maharashtra) facility
